Tarsus Pharmaceuticals, Inc. ($TARS)
Filing Information
| Accession Number | 0001788542-26-000007 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 19, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
13,056
Total Value
$892,528.42
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer | Common Stock | โ | Mar 17, 2026 | Sale | 4,286 | $69.42 | $297,534.12 | 70,250 | Direct | โ | View Details | |
Chief Commercial Officer | Common Stock | โ | Mar 18, 2026 | Sale | 4,330 | $68.71 | $297,514.30 | 65,920 | Direct | โ | View Details | |
Chief Commercial Officer | Common Stock | โ | Mar 19, 2026 | Sale | 4,440 | $67.00 | $297,480.00 | 61,480 | Direct | โ | View Details |